Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

ALAS PROPIAS: BMGIM for Professionals Working in Intimate Partner Machista Violence Services (ALAS PROPIAS)

3 de noviembre de 2026 actualizado por: Eva Maria Leon Zarceño, Universidad Miguel Hernandez de Elche

ALAS PROPIAS Program. Music Therapy, Well-Being and Psychological Health in the Context of Machista Violence in Intimate Partner Relationships: A Triangulation Study

This study evaluates the impact of a 10-session individual music therapy intervention using the Bonny Method of Guided Imagery and Music (BMGIM) on the well-being and psychological health of professionals working in services supporting women experiencing intimate partner machista violence.

The study uses a controlled, non-randomized quasi-experimental design, with an experimental group and a wait-list control group. Changes in burnout, compassion fatigue, vicarious trauma, secondary traumatic stress, anxiety, positive and negative affect, emotional regulation, and professional well-being are assessed.

Descripción general del estudio

Estado

Activo, no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

Professionals working in services supporting women experiencing intimate partner machista violence may experience psychological consequences associated with continued exposure to others' traumatic experiences, including burnout, compassion fatigue, vicarious trauma, and secondary traumatic stress.

This study examines the impact of an individual music therapy intervention based on the Bonny Method of Guided Imagery and Music (BMGIM), consisting of 10 individual sessions. Using a controlled, non-randomized quasi-experimental design, outcomes in the experimental group are compared with those in a wait-list control group.

Changes in vicarious trauma and secondary traumatic stress, burnout, compassion fatigue, anxiety, positive and negative affect, emotional regulation, and professional well-being are assessed. The study aims to contribute scientific evidence on the potential of BMGIM music therapy to support the well-being and psychological health of professionals working in contexts of intimate partner machista violence.

Tipo de estudio

Intervencionista

Inscripción (Actual)

54

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Alicante
      • Elche, Alicante, España, 03202
        • Universidad Miguel Hernández de Elche

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Professionals working in centers or shelters supporting women experiencing intimate partner machista violence.
  • Direct professional contact with cases of intimate partner violence.
  • Interest in participating in the individual BMGIM intervention and provision of informed consent.

Exclusion Criteria:

  • Active psychosis.
  • Unstabilized suicidal crisis.
  • Uncontrolled substance use that prevents participation.
  • Inability to attend weekly sessions

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: No aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Triple

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Individual BMGIM Music Therapy

Participants receive 10 individual music therapy sessions using the Bonny Method of Guided Imagery and Music (BMGIM).

The ALAS PROPIAS intervention consists of 10 individual music therapy sessions using the Bonny Method of Guided Imagery and Music (BMGIM), aimed at professionals working in services supporting women experiencing machista violence in intimate partner relationship. The intervention focuses on exploring imagery, emotions, and sensations through guided music listening, followed by a process of integration and reflection. The program aims to evaluate changes in burnout, compassion fatigue, vicarious trauma, secondary traumatic stress, anxiety, positive and negative affect, emotional regulation, psychological well-being, and professional well-being among participants.

Sin intervención: Control Group (Wait-List)

Participants complete the same assessments as the experimental group during the initial study period but do not receive the intervention during this phase. The intervention may be offered after the initial data collection, in accordance with the study protocol.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Burnout
Periodo de tiempo: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

Burnout will be assessed using the Spanish adaptation of the Maslach Burnout Inventory (MBI) (Maslach & Jackson, 1981; Seisdedos, 1997). Scores at the final assessment will be compared with baseline scores to evaluate changes in burnout among participants in the experimental and wait-list control groups.

Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)
Change in Positive and Negative Affect
Periodo de tiempo: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

Positive and negative affect will be assessed using the Spanish adaptation of the Positive and Negative Affect Schedule (PANAS) (Sandín et al., 1999). Scores at the final assessment will be compared with baseline scores to evaluate changes in positive and negative affect in the experimental and wait-list control groups.

Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)
Change in Psychological Well-Being
Periodo de tiempo: Psychological well-being will be assessed using the Spanish adaptation of Ryff's Psychological Well-Being Scales (Díaz et al., 2006). Scores at the final assessment will be compared with baseline scores to evaluate changes in psychological well-being in

Psychological well-being will be assessed using the Spanish adaptation of Ryff's Psychological Well-Being Scales (Díaz et al., 2006). Scores at the final assessment will be compared with baseline scores to evaluate changes in psychological well-being in the experimental and wait-list control groups.

Psychological well-being will be assessed using the Spanish adaptation of Ryff's Psychological Well-Being Scales (Díaz et al., 2006). Scores at the final assessment will be compared with baseline scores to evaluate changes in psychological well-being in
Change in Professional Quality of Life
Periodo de tiempo: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

Professional quality of life will be assessed using the Spanish adaptation of the Professional Quality of Life Scale, version 5 (ProQOL-5) (Galiana et al., 2020). Scores at the final assessment will be compared with baseline scores to evaluate changes in professional quality of life in the experimental and wait-list control groups.

Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)
Change in Secondary Traumatic Stress
Periodo de tiempo: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

Secondary traumatic stress will be assessed using the Secondary Traumatic Stress Scale (STSS) (Guerra & Saiz, 2007). Scores at the final assessment will be compared with baseline scores to evaluate changes in secondary traumatic stress in the experimental and wait-list control groups.

Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Eva Maria León Zarceño, Universidad Miguel Hernández de Elche.
  • Investigador principal: Vicente Alejandro March Luján, Catholic University of Valencia
  • Investigador principal: Marie Laure Rodríguez-Quiroga, Universidad Miguel Hernández de Elche.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

21 de abril de 2026

Finalización primaria (Estimado)

30 de noviembre de 2026

Finalización del estudio (Estimado)

30 de noviembre de 2026

Fechas de registro del estudio

Enviado por primera vez

3 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

3 de noviembre de 2026

Publicado por primera vez (Actual)

9 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

9 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

3 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • IDE.DEMLZ.MLRQ.24_2
  • IDE.DEMLZ.MLRQ.24 (Otro identificador: Universidad Miguel Hernández)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

De-identified individual participant data (IPD) underlying the primary and secondary outcomes will be made available to qualified researchers upon reasonable request submitted to the principal investigator. Data sharing will be subject to ethical review, a formal data-sharing agreement, and strict compliance with European Union GDPR regulations to safeguard minor participants' confidentiality.

Marco de tiempo para compartir IPD

Data will become available after the primary manuscript publishing the final longitudinal findings is accepted

Criterios de acceso compartido de IPD

Individual participant data will not be publicly shared to protect minor participants' confidentiality in compliance with GDPR and local data protection regulations. Aggregate data and protocol materials are available upon request

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .